Online Program Home
My Program

Keyword Search

Sessions Were Renumbered as of May 19.

Legend:
CC-W = McCormick Place Convention Center, West Building,   CC-N = McCormick Place Convention Center, North Building
H = Hilton Chicago,   UC= Conference Chicago at University Center
* = applied session       ! = JSM meeting theme

Keyword Search Criteria: Drug development returned 12 record(s)
Monday, 08/01/2016
Optimizing Graphical Multiple Testing Schemes in Late-Phase Drug Development
Eric Nantz, Eli Lilly and Company
9:35 AM

Tuesday, 08/02/2016
Value-Driven Decision Making at Late Stage of Drug Development: Statistical Simulation Approach
Masanori Ito, Astellas Pharma; Hideki Hirooka, Astellas Pharma


Comparison of Various Early-Phase Go/No Go Decision Criteria
Yili Pritchett, MedImmune; Masanori Ito, Astellas Pharma
8:35 AM

Value-Driven Decision Making at Late Stage of Drug Development: Statistical Simulation Approach
Masanori Ito, Astellas Pharma; Hideki Hirooka, Astellas Pharma
9:20 AM

Wednesday, 08/03/2016
Finding Optimal Combination in Cancer Drug Development: An Evidence Synthesis Approach
Sofia Paul, Novartis; Fei Ma, Novartis; Satrajit Roychoudhury, Novartis


An Extrapolation Framework to Specify Requirements for Drug Development in Children
Gerald Hlavin, Medical University of Vienna; Franz Koenig, Medical University of Vienna; Christoph Male, Medical University of Vienna; Martin Posch, Medical University of Vienna; Peter Bauer, Medical University of Vienna
9:35 AM

Global Challenges and Collaboration in Biopharmaceutical Statistics
Jose Pinheiro, Johnson & Johnson; Yuki Ando, Pharmaceutical and Medical Device Agency, Japan ; Frank Bretz, Novartis Pharma; Estelle Russek-Cohen, FDA; Abdus S. Wahed, University of Pittsburgh
10:35 AM

Some Consideration on Endpoint Selection, Weighting Determination, and Uncertainty Evaluation in the Benefit-Risk Assessment in Pharmaceutical Drug Development
Haijun Ma; Qi Jiang, Amgen
3:05 PM

Thursday, 08/04/2016
Comparison of Some Subgroup Identification Algorithms for Precision Medicine in Drug Development
Xin Huang; Yan Sun, AbbVie; Saptarshi Chatterjee, AbbVie; Viswanath Devanarayan, AbbVie
8:55 AM

Subgroup Identification in a Learn-and-Confirm Setting
Lei Shen, Eli Lilly and Company
9:55 AM

I Was a Statistician Before I Was a Pharmacometrician, I Swear!
Kevin Dykstra, Qpharmetra
10:35 AM

Overlap Between Statisticians and Pharmacometricians in Clinical Drug Development: Conflicts and Possible Resolutions
Ken Kowalski, Kowalski PMetrics Consulting
11:15 AM

 
 
Copyright © American Statistical Association